Essential Reads – Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles
This review article provides clinically relevant data but also helps the reader navigate some of the more controversial issues in the field.
Prospective Data on the Use of Newer Antipsychotics During Pregnancy: No Increase in Risk of Malformations
The most recent publication from the National Pregnancy Registry focuses on overall risk of malformations associated with the class of antipsychotic medications.
Prevalence of ADHD and Autism Spectrum Disorders in Children with Prenatal Exposure to Antipsychotic Medications
The findings of this study do not suggest that prenatal antipsychotics exposure is associated with increased risk for ADHD, ASD, small for gestational age, or preterm birth.
Essential Reads: Atypical Antipsychotics and Breastfeeding
Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, we have relatively little data on the use of these newer atypical agents in breastfeeding women.
New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole
Despite the increasing use of the newer atypical or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including psychotic disorders, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little [...]
Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes
Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic [...]
New Research from the CWMH: Gestational Weight Gain in Women Taking Second Generation Antipsychotics During Pregnancy
The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase. These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders. [...]
National Pregnancy Registry for Atypical Antipsychotics Milestone
We are excited to announce the enrollment of our 1000th participant in the National Pregnancy Registry for Atypical Antipsychotics! Formed in 2008, the Registry was established at MGH to prospectively evaluate the rates of [...]
New Research from the CWMH: Patterns of Atypical Antipsychotic Use During Pregnancy
The use of the newer “atypical” or second-generation antipsychotic agents is increasing. Atypical antipsychotics are now used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety [...]
Atypical Antipsychotics and Breastfeeding
Women with bipolar disorder are at a higher risk for relapse during pregnancy and that the risk is even higher during the postpartum period. In addition, women with bipolar disorder are more vulnerable to postpartum [...]